Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cardio Diagnostics's operating cash flow for the twelve months ending Dec 31, 2025 was -$5.73M. For fiscal 2025 it was -$5.73M. The highest annual figure on record is -$585.29K in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.73M | – |
| FY2024 | Dec 31, 2024 | -$4.99M | – |
| FY2023 | Dec 31, 2023 | -$5.67M | – |
| FY2022 | Dec 31, 2022 | -$5.09M | – |
| FY2021 | Dec 31, 2021 | -$585.29K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.36M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.21M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.23M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.69M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$394.77K | – |
| Q1 FY2022 | Mar 31, 2022 | -$186.09K | – |